Updated 2026-09-04 · NCT07533175See eligibility →
City
Clinical trials near Bologna, Italy
Active studies with a listed research site in Bologna, Italy.
11active studies
8recruiting now
20countries represented
74largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-08-27 · NCT07503210See eligibility →
Updated 2026-06-24 · NCT07666425See eligibility →
Recruiting nowNot applicable
Sustainable and Inclusive Use of Alternative Proteins in Mediterranean Supply Chains (CIPROMED)
Updated 2026-05-04 · NCT07553936See eligibility →
Recruiting nowNot applicable
Characterization and Phenotyping of Patients Who Are Offered Drug Therapy for Obesity
Updated 2026-02-17 · NCT07414043See eligibility →
Recruiting nowNot applicable
Copeptin and Thirst: Possible Predictive Markers of Effectiveness of Bariatric Surgery?
Updated 2025-02-04 · NCT06806787See eligibility →
Recruiting nowNot applicable
Cardiometabolic Risk of Obese Subjects: Cross-sectional Study
Updated 2024-12-05 · NCT06714058See eligibility →
Updated 2024-03-15 · NCT06308757See eligibility →
Active, not recruitingPhase 3
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
Updated 2026-08-06 · NCT07220642See eligibility →
Updated 2026-06-29 · NCT06075667See eligibility →
Active, not recruitingNot applicable
Observational Study of Eating Behavior in Patients With Diabetes Mellitus and Obesity Undergoing Liver Transplantation
Updated 2024-12-04 · NCT06714786See eligibility →
Related cities
Beijing, China123Boston, United States76Houston, United States75Shanghai, China74Chicago, United States70New York, United States59
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.